Aurobindo Pharma posts consolidated Q1FY23 PAT of Rs. 520.54 Cr
News

Aurobindo Pharma posts consolidated Q1FY23 PAT of Rs. 520.54 Cr

The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.

  • By IPP Bureau | August 12, 2022

Aurobindo Pharma Limited has net profit of Rs. 520.54 crores for the period ended June 30, 2022 as against net profit of Rs. 576.46 crores for the period ended March 31, 2022. The company posted net profit of Rs.769.97 crores for the period ended June 30, 2021.

The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022 as compared to Rs. 5858.25 crores during the period ended March 31, 2022. It reported total income Rs.5811.88 crores during the period ended June 30, 2021.

Upcoming E-conference

Other Related stories

Startup

Digitization